Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
01/2004
01/14/2004CN1466994A Compositions and therapeutic use
01/14/2004CN1466988A Chinese materia medica preparation for treating burn and scald and method for preparing the same
01/14/2004CN1466976A Medicine for preventing and curing rachitis and osteoporosis and method for preparing the same
01/14/2004CN1466953A Composite preparation for preventing and treating agedness degeneration of macula
01/14/2004CN1134263C Liniment for repairing scratched face without residual scar
01/14/2004CN1134262C Medicine for treating toothache and method for preparing the same
01/13/2004US6676977 Pharmaceutical compositions and methods for reducing the appearance of cellulite
01/13/2004US6676973 Method of treating ovarian cancers with cadmium
01/13/2004US6676953 For treating fungal infections of human fingernails and toenails, and for alleviating other symptoms often associated with such fungal infections
01/13/2004US6676947 Use of erythropoietin for the treatment of haemochromatoses
01/08/2004WO2004002467A1 Peritoneal dialysate containing taurine
01/08/2004WO2004002384A1 Antimicrobial, silver-containing wound dressing for continuous release
01/08/2004WO2003092647A3 Transport system in biological systems
01/08/2004WO2003062149A3 Antimicrobial composition including a triamine and a biocide
01/08/2004WO2002092075A3 Therapeutic delivery of carbon monoxide
01/08/2004WO2002036202A3 Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
01/08/2004US20040006778 Comprises heat resistant polypeptide for preparing pharmaceuticals; drug biosynthesis; side effect reduction
01/08/2004US20040006111 Transmucosal delivery of proton pump inhibitors
01/08/2004US20040006087 Method of treating cancer using FPT inhibitors and antineoplastic agents
01/08/2004US20040006044 For therapy and prophylaxis
01/08/2004US20040006043 Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents
01/08/2004US20040005621 Method of determining a chemotherapeutic regimen based on ERCC1 expression
01/08/2004US20040005368 Enhancing lipolysis and the suppression of appetite are presented. Currently the preferred embodiment has these formulations as two separate compositions because of taste considerations. It is known that the two separate compositions
01/08/2004US20040005367 Methods of treating necrotizing enterocolitis
01/08/2004US20040005366 Healthy bone formulation
01/08/2004US20040005365 Carcinostatic substance for compatible administration, process of administrating same and process of rapidly inspecting same
01/08/2004US20040005311 Including a core of lysine and bromelain and, optionally, including lycopene; can be used to alleviate dementia-related symptoms.
01/08/2004US20040005305 Nutritional composition for treating an immune condition
01/08/2004US20040005304 Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
01/08/2004US20040003757 Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface
01/08/2004DE10204207A1 Mittel zur Anregung des körpereigenen Energieflusses bestehend aus einem um ein Kupferplätchen gelegtes Magnetfeld Means of stimulating the body's energy flow consisting of a magnetic field placed around a Kupferplätchen
01/08/2004DE10057290B4 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten To be administered enterally supplement for parenteral nutrition or partial enteral / oral nutrition in critically ill patients, chronically ill and malnourished
01/07/2004EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma
01/07/2004EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma
01/07/2004EP1378177A1 Vitamin-containing system for stabilising the immune response of animals
01/07/2004EP1377300A1 Zinc ionophores as anti-stress agents
01/07/2004EP0855900B1 A depilatory composition with improved rinsing properties
01/07/2004EP0724436B1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
01/07/2004CN1466454A Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract
01/07/2004CN1133463C Pharmaceutical combination preparations containing erythropoietin and iron preparation
01/07/2004CN1133456C Liquid medicine for curing beriberi
01/07/2004CN1133454C Bone invigorating composition contaninig yak bone and its prepn
01/07/2004CN1133452C Chunren liver recovering capsule
01/07/2004CN1133416C Skin-care cosmetics containing peroxide
01/07/2004CN1133405C Products capable of emitting far infrared ray and method for using far infrared ray
01/06/2004US6673782 Treating proteinuria and swollen lymph node symptoms by administering an effective dose of a vitamin d analog to a patient on a diet which includes a calcium intake level of >800mg/day per 160 pound patient
01/06/2004US6673376 Dissolving in container solid acid and salt; mixing acid-reacting component with the alkaline reacting bicarbonate; storage
01/06/2004US6673375 Mostly comprising sodium metasilicate (pentahydrate) and shows nonspecific immunostimulating activity in plants and animals
01/06/2004US6673374 Pharmaceutical compositions and methods for managing skin conditions
01/06/2004US6673370 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
01/02/2004EP1375434A1 Method and device for manufacturing advanced water containing ultra-fine gold particles
01/02/2004EP1374904A1 Preparation containing polymethyl-siloxane for nails, cartilage, bone joint, muscle and tendon disorders
01/02/2004EP1374881A1 A pharmaceutical preparation for asthma
01/02/2004EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome
01/02/2004EP1374874A2 Liquid antacid compositions
01/02/2004EP1374832A1 Cosmetics to promote maturation of cornified envelope and method for treatment
01/02/2004EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions
01/02/2004EP1372717A2 Combination treatment of pancreatic cancer
01/02/2004EP1372676A1 Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection
01/02/2004EP1372658A2 Methods of treating cancer using cyplastin combined with a dioxolane nucleoside such as troxacitabine
01/02/2004EP1372650A2 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
01/02/2004EP1372633A1 Irrigating fluid
01/02/2004EP1372631A1 Method and formula for anti-tumor and anti-matastatic effect
01/02/2004EP1372629A2 Therapeutic treatment
01/02/2004EP1372572A2 Use of ozone for the treatment of dental and oral conditions
01/02/2004EP1372389A2 Virucidal compositions
01/02/2004EP0746343B1 Bioartificial kidney devices coated with cells suitable for use in vivo or ex vivo
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
01/01/2004US20040002454 Administering polypeptides; cardiovascular disorders
01/01/2004US20040001880 Wound dressing
01/01/2004US20040001817 Mixture of vitamions, minerals, digestive enzyme, hormone and amino acids
01/01/2004US20040001791 Composition, method of use, and devices for the treatment of onychomycosis
12/2003
12/31/2003WO2004000372A2 Disinfecting composition, cleaning tablet produced therefrom, and use thereof
12/31/2003WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles
12/31/2003WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003WO2004000364A1 Preparation containing polydimethylsiloxane for nails, cartilage, bone joint, muscle and tendon disorders
12/31/2003WO2004000303A1 Method for therapeutic modality on a patient organism during the cure of parkinson's disease
12/31/2003WO2004000293A2 Use of taurine or derivatives thereof for the treatment of alopecia
12/31/2003WO2004000291A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails
12/31/2003WO2004000277A1 Resorbable delivery systems for the treatment of cancer
12/31/2003WO2004000271A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis
12/31/2003WO2004000244A1 Cosmetic compositions comprising small magnetic particles
12/31/2003WO2004000025A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
12/31/2003WO2003087308A3 Use of interleukin-24 to treat ovarian cancer
12/31/2003WO2003065392A3 Photovoltaic cell interconnection
12/31/2003WO2003042404A3 Breast cancer eradication program
12/31/2003CN1464788A Pharmaceutical compositions for headache, migraine, nausea and emesis
12/31/2003CN1463738A A medicine for treating scald and burn, and method for preparing same
12/31/2003CN1463706A Bingliushui traditional Chinese medicament
12/31/2003CN1132621C Tibetans medicine for treating cardiac and cerebral vascular disease and white pulse disease
12/31/2003CN1132619C Medicine for treating myopia
12/31/2003CN1132612C Medicine for treating rheumatism and cold pain and its utilizing method
12/31/2003CN1132602C Full-natural medicine for treating calculus
12/31/2003CN1132589C Process for preparing plaster to promote circulation of blood and vital energy
12/31/2003CN1132587C Preparation method of medicine for curing surgical diseases of traditional Chinese medicine
12/31/2003CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2489308A1 Use of taurine for the treatment of alopecia
12/30/2003US6670392 Administering vitamin e and selenium, or compound thereof
12/30/2003US6669981 Light stabilized antimicrobial materials